128 related articles for article (PubMed ID: 6149299)
1. Gas chromatographic-mass spectrometric assay for the ultra-short-acting beta-blocker esmolol.
Sum CY; Yacobi A
J Pharm Sci; 1984 Aug; 73(8):1177-9. PubMed ID: 6149299
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite.
Sum CY; Yacobi A; Kartzinel R; Stampfli H; Davis CS; Lai CM
Clin Pharmacol Ther; 1983 Oct; 34(4):427-34. PubMed ID: 6617063
[TBL] [Abstract][Full Text] [Related]
3. Simple and rapid high-performance liquid chromatographic assay for esmolol.
Fan CD; Zhao H; Chow MS
J Chromatogr; 1991 Sep; 570(1):217-23. PubMed ID: 1686774
[TBL] [Abstract][Full Text] [Related]
4. Esmolol, an ultrashort-acting, selective beta 1-adrenoceptor antagonist: pharmacodynamic and pharmacokinetic properties.
Volz-Zang C; Eckrich B; Jahn P; Schneidrowski B; Schulte B; Palm D
Eur J Clin Pharmacol; 1994; 46(5):399-404. PubMed ID: 7957532
[TBL] [Abstract][Full Text] [Related]
5. High-performance liquid chromatographic assay for the major blood metabolite of esmolol--an ultra short acting beta blocker.
Stampfli HF; Lai CM; Yacobi A; Sum CY
J Chromatogr; 1984 Jul; 309(1):203-8. PubMed ID: 6148350
[No Abstract] [Full Text] [Related]
6. Pharmacodynamics and onset of action of esmolol in anesthetized dogs.
Quon CY; Gorczynski RJ
J Pharmacol Exp Ther; 1986 Jun; 237(3):912-8. PubMed ID: 2872328
[TBL] [Abstract][Full Text] [Related]
7. Determination of esmolol in serum by capillary zone electrophoresis and its monitoring in course of heart surgery.
Malovaná S; Gajdosová D; Benedík J; Havel J
J Chromatogr B Biomed Sci Appl; 2001 Aug; 760(1):37-43. PubMed ID: 11522064
[TBL] [Abstract][Full Text] [Related]
8. Liquid chromatography-electrospray mass spectrometry (LC-MS) method for determination of esmolol concentration in human plasma.
Zuppa AF; Shi H; Adamson PC
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Nov; 796(2):293-301. PubMed ID: 14581069
[TBL] [Abstract][Full Text] [Related]
9. Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics.
Wiest D
Clin Pharmacokinet; 1995 Mar; 28(3):190-202. PubMed ID: 7758250
[TBL] [Abstract][Full Text] [Related]
10. Ultra-short-acting beta-blockade: a comparison with conventional beta-blockade.
Reilly CS; Wood M; Koshakji RP; Wood AJ
Clin Pharmacol Ther; 1985 Nov; 38(5):579-85. PubMed ID: 2865029
[TBL] [Abstract][Full Text] [Related]
11. Determination of betaxolol, a new beta-blocker, by gas chromatography mass spectrometry: application to pharmacokinetic studies.
Hermann P; Fraisse J; Allen J; Morselli PL; Thenot JP
Biomed Mass Spectrom; 1984 Jan; 11(1):29-34. PubMed ID: 6142735
[TBL] [Abstract][Full Text] [Related]
12. Metabolism and urinary excretion of esmolol in humans.
Achari R; Drissel D; Matier WL; Hulse JD
J Clin Pharmacol; 1986 Jan; 26(1):44-7. PubMed ID: 2869058
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of esmolol and ASL-8123 in renal failure.
Flaherty JF; Wong B; La Follette G; Warnock DG; Hulse JD; Gambertoglio JG
Clin Pharmacol Ther; 1989 Mar; 45(3):321-7. PubMed ID: 2563962
[TBL] [Abstract][Full Text] [Related]
14. Clinical rationale for the use of an ultra-short acting beta-blocker: esmolol.
Barbier GH; Shettigar UR; Appunn DO
Int J Clin Pharmacol Ther; 1995 Apr; 33(4):212-8. PubMed ID: 7620691
[TBL] [Abstract][Full Text] [Related]
15. Use of dodecyl sulfate as an esterase inhibitor before gas-chromatographic determination of labile beta-adrenoceptor blocking drugs.
Holm G; Kylberg-Hanssen K; Svensson L
Clin Chem; 1985 Jun; 31(6):868-70. PubMed ID: 2859935
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of esmolol in pediatric subjects with supraventricular arrhythmias.
Adamson PC; Rhodes LA; Saul JP; Dick M; Epstein MR; Moate P; Boston R; Schreiner MS
Pediatr Cardiol; 2006; 27(4):420-7. PubMed ID: 16835806
[TBL] [Abstract][Full Text] [Related]
17. Quantitation of the ultra short acting beta-adrenergic antagonist flestolol in blood by liquid chromatography.
Moore P; Mai K; Lai CM
J Pharm Sci; 1986 Apr; 75(4):424-6. PubMed ID: 2873234
[TBL] [Abstract][Full Text] [Related]
18. Esmolol-digoxin drug interaction.
Lowenthal DT; Porter RS; Achari R; Turlapaty P; Laddu AR; Matier WL
J Clin Pharmacol; 1987 Aug; 27(8):561-6. PubMed ID: 2888792
[TBL] [Abstract][Full Text] [Related]
19. Determination of orally coadministered nadolol and its deuterated analogue in human serum and urine by gas chromatography with selected-ion monitoring mass spectrometry.
Cohen AI; Devlin RG; Ivashkiv E; Funke PT; McCormick T
J Pharm Sci; 1984 Nov; 73(11):1571-5. PubMed ID: 6151597
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of esmolol in anesthetized patients receiving chronic beta blocker therapy.
de Bruijn NP; Reves JG; Croughwell N; Clements F; Drissel DA
Anesthesiology; 1987 Mar; 66(3):323-6. PubMed ID: 2881504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
